Skip to main content

Table 4 Competing risks regression model for risk of death from non-small cell lung cancer NSW 2001–2007a

From: Lung cancer treatment and mortality for Aboriginal people in New South Wales, Australia: results from a population-based record linkage study and medical record audit

Variable name

Subhazard ratiob (95 % CI)

p-value

Aboriginal

1.32 (1.14–1.52)

<0.001

Sex

 

0.001

 Male

1.00

 

 Female

1.07 (1.03–1.11)

 

Age at diagnosis

 

<0.001

 18–50

1.00

 

 50–59

1.22 (1.11–1.35)

 

 60–69

1.32 (1.20–1.45)

 

 70–79

1.51 (1.37–1.66)

 

  > =80

1.89 (1.71–2.09)

 

Spread of disease

 

<0.001

 Localised

1.00

 

 Regional

1.46 (1.37–1.55)

 

 Distant

2.58 (2.44–2.73)

 

 Unknown

1.13 (1.06–1.20)

 

Year of diagnosis

0.97 (0.96–0.98)

<0.001

Surgical treatmentc

 

<0.001

 Did not have surgical treatment

1.00

 

 Had surgical treatment

0.27 (0.25–0.28)

 

Place of residence at diagnosis

 

0.889

 Major cities

1.00

 

 Inner regional

0.99 (0.94–1.05)

 

 Rurald

1.01 (0.93–1.10)

 

Comorbiditiese

  

 Diabetes

1.00 (0.94–1.06)

0.976

 Cardiovascular disease

0.98 (0.93–1.04)

0.575

 Chronic pulmonary disease

1.18 (1.12–1.23)

<0.001

 Renal disease

0.94 (0.84–1.05)

0.280

 Other comorbidities

1.14 (1.07–1.22)

<0.001

Socioeconomic disadvantage quintile

<0.001

 Least disadvantaged

1.00

 

 Second least disadvantaged

1.04 (0.98–1.11)

 

 Third least disadvantaged

1.17 (1.09–1.25)

 

 Second most disadvantaged

1.11 (1.04–1.19)

 

 Most disadvantaged

1.12 (1.04–1.20)

 

Smoking status

 

0.149

 Never smoker

1.00

 

 Current smoker

1.03 (0.98–1.08)

 

 Ever smoker

1.06 (1.00–1.12)

 

 Ex smoker

0.99 (0.93–1.05)

 

 Unknown

1.01 (0.87–1.17)

 
  1. CI confidence interval
  2. aThere were 266 Aboriginal and 15,491 non-Aboriginal people in this analysis
  3. bSubhazard ratio adjusted for all other variables in the table
  4. cSurgical treatment included pneumonectomy, lobectomy, lung resection or resection of endotracheal tumour
  5. dRural includes outer regional, remote and very remote
  6. ePresence vs absence of each comorbidity